BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

949 related articles for article (PubMed ID: 10473086)

  • 1. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
    Apisarnthanarax N; Wood GS; Stevens SR; Carlson S; Chan DV; Liu L; Szabo SK; Fu P; Gilliam AC; Gerson SL; Remick SC; Cooper KD
    Arch Dermatol; 2012 May; 148(5):613-20. PubMed ID: 22250189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of environmental alkylating agents to repair protein O6-alkylguanine-DNA alkyltransferase: determination of individual and collective repair capacities of O6-methylguanine.
    Oesch F; Klein S
    Cancer Res; 1992 Apr; 52(7):1801-3. PubMed ID: 1532345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
    Izban KF; Hsi ED; Alkan S
    Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
    Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
    JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of mutations in the hprt gene of normal human skin keratinocytes treated with N-ethyl-N-nitrosourea: influence of O6-alkylguanine alkyltransferase.
    Tong HH; Park JH; Brady T; Weghorst CM; D'Ambrosio SM
    Environ Mol Mutagen; 1997; 29(2):168-79. PubMed ID: 9118969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-time fluorescence assay for O6-alkylguanine-DNA alkyltransferase.
    Moser AM; Patel M; Yoo H; Balis FM; Hawkins ME
    Anal Biochem; 2000 Jun; 281(2):216-22. PubMed ID: 10870838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the O6-alkylguanine-DNA alkyltransferase gene is elevated in human breast tumor cells.
    Wani G; D'Ambrosio SM
    Anticancer Res; 1997; 17(6D):4311-5. PubMed ID: 9494526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of domains of human O6-alkylguanine-DNA alkyltransferase.
    Fang Q; Kanugula S; Pegg AE
    Biochemistry; 2005 Nov; 44(46):15396-405. PubMed ID: 16285744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells.
    Liu L; Lee K; Schupp J; Koç ON; Gerson SL
    Clin Cancer Res; 1998 Feb; 4(2):475-81. PubMed ID: 9516939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence context affects repair of the tobacco-specific adduct O(6)-[4-Oxo-4-(3-pyridyl)butyl]guanine by human O(6)-alkylguanine-DNA alkyltransferases.
    Mijal RS; Kanugula S; Vu CC; Fang Q; Pegg AE; Peterson LA
    Cancer Res; 2006 May; 66(9):4968-74. PubMed ID: 16651455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair.
    Souliotis VL; Kaila S; Boussiotis VA; Pangalis GA; Kyrtopoulos SA
    Cancer Res; 1990 May; 50(9):2759-64. PubMed ID: 2328502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
    de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
    Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.